BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Choi SM, Boudreault AA, Xie H, Englund JA, Corey L, Boeckh M. Differences in clinical outcomes after 2009 influenza A/H1N1 and seasonal influenza among hematopoietic cell transplant recipients. Blood 2011;117:5050-6. [PMID: 21372154 DOI: 10.1182/blood-2010-11-319186] [Cited by in Crossref: 101] [Cited by in F6Publishing: 85] [Article Influence: 9.2] [Reference Citation Analysis]
Number Citing Articles
1 Saad M, Hayajneh W, Mubarak S, Yousef I, Awad H, Elbjeirami W, Rihani R. Clinical presentations and outcomes of influenza infection among hematology/oncology patients from a single cancer center: pandemic and post-pandemic seasons. Scand J Infect Dis. 2014;46:770-778. [PMID: 25134648 DOI: 10.3109/00365548.2014.943282] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.8] [Reference Citation Analysis]
2 Cordonnier C, Einarsdottir S, Cesaro S, Di Blasi R, Mikulska M, Rieger C, de Lavallade H, Gallo G, Lehrnbecher T, Engelhard D, Ljungman P; European Conference on Infections in Leukaemia group. Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7). Lancet Infect Dis 2019;19:e200-12. [PMID: 30744963 DOI: 10.1016/S1473-3099(18)30600-5] [Cited by in Crossref: 76] [Cited by in F6Publishing: 30] [Article Influence: 25.3] [Reference Citation Analysis]
3 Gooskens J, Marijt WA, van Essen EH, Rimmelzwaan GF, Kroes AC. Host immunity dictates influenza A(H1N1)pdm09 infection outcome in hematology-oncology patients. Bone Marrow Transplant 2016;51:138-41. [PMID: 26389836 DOI: 10.1038/bmt.2015.214] [Cited by in Crossref: 3] [Article Influence: 0.4] [Reference Citation Analysis]
4 Ison MG, Hirsch HH. Community-Acquired Respiratory Viruses in Transplant Patients: Diversity, Impact, Unmet Clinical Needs. Clin Microbiol Rev 2019;32:e00042-19. [PMID: 31511250 DOI: 10.1128/CMR.00042-19] [Cited by in Crossref: 41] [Cited by in F6Publishing: 21] [Article Influence: 13.7] [Reference Citation Analysis]
5 Shah DP, El Taoum KK, Shah JN, Vigil KJ, Adachi JA, Granwehr BP, Tarrand JJ, Raad II, Chemaly RF. Characteristics and outcomes of pandemic 2009/H1N1 versus seasonal influenza in children with cancer. Pediatr Infect Dis J 2012;31:373-8. [PMID: 22228234 DOI: 10.1097/INF.0b013e3182481ef8] [Cited by in Crossref: 20] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
6 Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C, Roccia-Rossi I, Stecher D, Carbone E, Laborde A, Efron E, Altclas J, Calmaggi A, Cozzi J. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res 2014;3:221. [PMID: 25469231 DOI: 10.12688/f1000research.5251.2] [Cited by in Crossref: 19] [Cited by in F6Publishing: 6] [Article Influence: 2.4] [Reference Citation Analysis]
7 Cherif H, Höglund M, Pauksens K. Adjuvanted influenza a (H1N1) 2009 vaccine in patients with hematological diseases: good safety and immunogenicity even in chemotherapy-treated patients. Eur J Haematol 2013;90:413-9. [DOI: 10.1111/ejh.12094] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
8 Dignani MC, Costantini P, Salgueira C, Jordán R, Guerrini G, Valledor A, Herrera F, Nenna A, Mora C, Roccia-Rossi I, Stecher D, Carbone E, Laborde A, Efron E, Altclas J, Calmaggi A, Cozzi J. Pandemic 2009 Influenza A (H1N1) virus infection in cancer and hematopoietic stem cell transplant recipients; a multicenter observational study. F1000Res 2014;3:221. [PMID: 25469231 DOI: 10.12688/f1000research.5251.2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 15] [Article Influence: 0.3] [Reference Citation Analysis]
9 Pochon C, Voigt S. Respiratory Virus Infections in Hematopoietic Cell Transplant Recipients. Front Microbiol 2018;9:3294. [PMID: 30687278 DOI: 10.3389/fmicb.2018.03294] [Cited by in Crossref: 22] [Cited by in F6Publishing: 16] [Article Influence: 7.3] [Reference Citation Analysis]
10 Roll D, Ammer J, Holler B, Salzberger B, Schweiger B, Jilg W, Andreesen R, Edinger M, Wolff D, Holler E. Vaccination against pandemic H1N1 (2009) in patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis. Infection 2012;40:153-61. [PMID: 22038110 DOI: 10.1007/s15010-011-0206-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.4] [Reference Citation Analysis]
11 Teh BW, Worth LJ, Harrison SJ, Thursky KA, Slavin MA. Risks and burden of viral respiratory tract infections in patients with multiple myeloma in the era of immunomodulatory drugs and bortezomib: experience at an Australian Cancer Hospital. Support Care Cancer 2015;23:1901-6. [PMID: 25487843 DOI: 10.1007/s00520-014-2550-3] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 2.3] [Reference Citation Analysis]
12 Lee DG. Vaccination of hematopoietic stem cell transplantation recipients: perspective in Korea. Infect Chemother 2013;45:272-82. [PMID: 24396628 DOI: 10.3947/ic.2013.45.3.272] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
13 Bresee JS, Fry AM, Sambhara S, Cox NJ. Inactivated Influenza Vaccines. Plotkin's Vaccines. Elsevier; 2018. pp. 456-488.e21. [DOI: 10.1016/b978-0-323-35761-6.00031-6] [Cited by in Crossref: 6] [Article Influence: 1.5] [Reference Citation Analysis]
14 Brotons P, Henares D, Latorre I, Cepillo A, Launes C, Muñoz-Almagro C. Comparison of NxTAG Respiratory Pathogen Panel and Anyplex II RV16 Tests for Multiplex Detection of Respiratory Pathogens in Hospitalized Children. J Clin Microbiol 2016;54:2900-4. [PMID: 27629904 DOI: 10.1128/JCM.01243-16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
15 Sutrave G, Gottlieb DJ. Adoptive cell therapies for posttransplant infections. Curr Opin Oncol 2019;31:574-90. [PMID: 31593976 DOI: 10.1097/CCO.0000000000000580] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
16 Chen YY, Luo XY, Zhao XS, Jiang ZH, Chen Y, Chen H, Mo XD, Han W, Wang FR, Wang JZ, Yan CH, Sun YQ, Zhang YY, Han TT, Tang FF, Fu HX, Zhang S, Wang Y, Xu LP, Zhang XH, Liu KY, Huang XJ. [Clinical value of PCR for viral detection of bronchoalveolar lavage fluid in the diagnosis and treatment of pneumonia after allogeneic hematopoietic stem cell transplantation]. Zhonghua Xue Ye Xue Za Zhi 2017;38:934-9. [PMID: 29224314 DOI: 10.3760/cma.j.issn.0253-2727.2017.11.006] [Reference Citation Analysis]
17 Fukatsu Y, Nagata Y, Adachi M, Yagyu T, Ono T. Serum IgM levels independently predict immune response to influenza vaccine in long-term survivors vaccinated at >1 year after undergoing allogeneic hematopoietic stem cell transplantation. Int J Hematol 2017;105:638-45. [DOI: 10.1007/s12185-016-2163-3] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
18 Punpanich W, Chotpitayasunondh T. A review on the clinical spectrum and natural history of human influenza. International Journal of Infectious Diseases 2012;16:e714-23. [DOI: 10.1016/j.ijid.2012.05.1025] [Cited by in Crossref: 41] [Cited by in F6Publishing: 27] [Article Influence: 4.1] [Reference Citation Analysis]
19 Legoff J, Zucman N, Lemiale V, Mokart D, Pène F, Lambert J, Kouatchet A, Demoule A, Vincent F, Nyunga M, Bruneel F, Contejean A, Mercier-Delarue S, Rabbat A, Lebert C, Perez P, Meert AP, Benoit D, Schwebel C, Jourdain M, Darmon M, Resche-Rigon M, Azoulay E. Clinical Significance of Upper Airway Virus Detection in Critically Ill Hematology Patients. Am J Respir Crit Care Med 2019;199:518-28. [PMID: 30230909 DOI: 10.1164/rccm.201804-0681OC] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 7.5] [Reference Citation Analysis]
20 Khatri M, Saif YM. Influenza virus infects bone marrow mesenchymal stromal cells in vitro: implications for bone marrow transplantation. Cell Transplant 2013;22:461-8. [PMID: 23006541 DOI: 10.3727/096368912X656063] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 1.8] [Reference Citation Analysis]
21 Ljungman P, de la Camara R, Mikulska M, Tridello G, Aguado B, Zahrani MA, Apperley J, Berceanu A, Bofarull RM, Calbacho M, Ciceri F, Lopez-Corral L, Crippa C, Fox ML, Grassi A, Jimenez MJ, Demir SK, Kwon M, Llamas CV, Lorenzo JLL, Mielke S, Orchard K, Porras RP, Vallisa D, Xhaard A, Knelange NS, Cedillo A, Kröger N, Piñana JL, Styczynski J. COVID-19 and stem cell transplantation; results from an EBMT and GETH multicenter prospective survey. Leukemia 2021. [PMID: 34079042 DOI: 10.1038/s41375-021-01302-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 8] [Article Influence: 3.0] [Reference Citation Analysis]
22 Uyeki TM, Bernstein HH, Bradley JS, Englund JA, File TM, Fry AM, Gravenstein S, Hayden FG, Harper SA, Hirshon JM, Ison MG, Johnston BL, Knight SL, McGeer A, Riley LE, Wolfe CR, Alexander PE, Pavia AT. Clinical Practice Guidelines by the Infectious Diseases Society of America: 2018 Update on Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management of Seasonal Influenzaa. Clin Infect Dis 2019;68:e1-e47. [PMID: 30566567 DOI: 10.1093/cid/ciy866] [Cited by in Crossref: 166] [Cited by in F6Publishing: 155] [Article Influence: 83.0] [Reference Citation Analysis]
23 Abed Y, Carbonneau J, L'Huillier AG, Kaiser L, Boivin G. Droplet digital PCR to investigate quasi-species at codons 119 and 275 of the A(H1N1)pdm09 neuraminidase during zanamivir and oseltamivir therapies. J Med Virol 2017;89:737-41. [PMID: 27602879 DOI: 10.1002/jmv.24680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
24 Durani U, Dioverti Prono MV, Tosh PK, Patnaik M, Barreto JN, Tande AJ. Influenza infection in neutropenic adults. Infect Dis (Lond) 2017;49:141-6. [PMID: 27636702 DOI: 10.1080/23744235.2016.1231418] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
25 Lansbury L, Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev 2019;2:CD010406. [PMID: 30798570 DOI: 10.1002/14651858.CD010406.pub3] [Cited by in Crossref: 26] [Cited by in F6Publishing: 55] [Article Influence: 8.7] [Reference Citation Analysis]
26 Versluys AB, Boelens JJ. Morbidity and Mortality Associated With Respiratory Virus Infections in Allogeneic Hematopoietic Cell Transplant: Too Little Defense or Harmful Immunity? Front Microbiol 2018;9:2795. [PMID: 30519222 DOI: 10.3389/fmicb.2018.02795] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
27 Dignan FL, Clark A, Aitken C, Gilleece M, Jayakar V, Krishnamurthy P, Pagliuca A, Potter MN, Shaw B, Skinner R, Turner A, Wynn RF, Coyle P; Haemato-oncology Task Force of the British Committee for Standards in Haematology., British Society for Blood and Marrow Transplantation and the UK Clinical Virology Network. BCSH/BSBMT/UK clinical virology network guideline: diagnosis and management of common respiratory viral infections in patients undergoing treatment for haematological malignancies or stem cell transplantation. Br J Haematol 2016;173:380-93. [PMID: 27060988 DOI: 10.1111/bjh.14027] [Cited by in Crossref: 31] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
28 Ángeles-Sistac D, Martin-Onraet A, Cornejo-Juárez P, Volkow P, Pérez-Jimenez C, Vilar-Compte D. Influenza in patients with cancer after 2009 pandemic AH1N1: An 8-year follow-up study in Mexico. Influenza Other Respir Viruses 2020;14:196-203. [PMID: 31747133 DOI: 10.1111/irv.12704] [Cited by in F6Publishing: 8] [Reference Citation Analysis]
29 Roosenhoff R, van der Vries E, van der Linden A, van Amerongen G, Stittelaar KJ, Smits SL, Schutten M, Fouchier RAM. Influenza A/H3N2 virus infection in immunocompromised ferrets and emergence of antiviral resistance. PLoS One 2018;13:e0200849. [PMID: 30024940 DOI: 10.1371/journal.pone.0200849] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 2.8] [Reference Citation Analysis]
30 von Lilienfeld-Toal M, Berger A, Christopeit M, Hentrich M, Heussel CP, Kalkreuth J, Klein M, Kochanek M, Penack O, Hauf E, Rieger C, Silling G, Vehreschild M, Weber T, Wolf HH, Lehners N, Schalk E, Mayer K. Community acquired respiratory virus infections in cancer patients-Guideline on diagnosis and management by the Infectious Diseases Working Party of the German Society for haematology and Medical Oncology. Eur J Cancer 2016;67:200-12. [PMID: 27681877 DOI: 10.1016/j.ejca.2016.08.015] [Cited by in Crossref: 48] [Cited by in F6Publishing: 30] [Article Influence: 8.0] [Reference Citation Analysis]
31 Paulsen GC, Danziger-Isakov L. Respiratory Viral Infections in Solid Organ and Hematopoietic Stem Cell Transplantation. Clin Chest Med 2017;38:707-26. [PMID: 29128020 DOI: 10.1016/j.ccm.2017.07.012] [Cited by in Crossref: 27] [Cited by in F6Publishing: 19] [Article Influence: 5.4] [Reference Citation Analysis]
32 Wagner AL, Gresh L, Sanchez N, Kuan G, Kubale J, Lopez R, Ojeda S, Azziz-Baumgartner E, Balmaseda A, Gordon A. Influenza Illness and Partial Vaccination in the First Two Years of Life. Vaccines (Basel) 2021;9:676. [PMID: 34203000 DOI: 10.3390/vaccines9060676] [Reference Citation Analysis]
33 Salvatore M, Laplante JM, Soave R, Orfali N, Plate M, Besien K, St. George K. Baloxavir for the treatment of Influenza in allogeneic hematopoietic stem cell transplant recipients previously treated with oseltamivir. Transpl Infect Dis 2020;22. [DOI: 10.1111/tid.13336] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
34 Hurt AC, Hui DS, Hay A, Hayden FG. Overview of the 3rd isirv-Antiviral Group Conference--advances in clinical management. Influenza Other Respir Viruses 2015;9:20-31. [PMID: 25399715 DOI: 10.1111/irv.12293] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 1.8] [Reference Citation Analysis]
35 Seo S, Englund JA, Nguyen JT, Pukrittayakamee S, Lindegardh N, Tarning J, Tambyah PA, Renaud C, Went GT, de Jong MD, Boeckh MJ. Combination therapy with amantadine, oseltamivir and ribavirin for influenza A infection: safety and pharmacokinetics. Antivir Ther 2013;18:377-86. [PMID: 23264438 DOI: 10.3851/IMP2475] [Cited by in Crossref: 47] [Cited by in F6Publishing: 24] [Article Influence: 4.7] [Reference Citation Analysis]
36 Chemaly RF, Shah DP, Boeckh MJ. Management of respiratory viral infections in hematopoietic cell transplant recipients and patients with hematologic malignancies. Clin Infect Dis 2014;59 Suppl 5:S344-51. [PMID: 25352629 DOI: 10.1093/cid/ciu623] [Cited by in Crossref: 122] [Cited by in F6Publishing: 99] [Article Influence: 17.4] [Reference Citation Analysis]
37 Engelhard D, Mohty B, de la Camara R, Cordonnier C, Ljungman P. European guidelines for prevention and management of influenza in hematopoietic stem cell transplantation and leukemia patients: summary of ECIL-4 (2011), on behalf of ECIL, a joint venture of EBMT, EORTC, ICHS, and ELN. Transpl Infect Dis 2013;15:219-32. [DOI: 10.1111/tid.12054] [Cited by in Crossref: 73] [Cited by in F6Publishing: 60] [Article Influence: 8.1] [Reference Citation Analysis]
38 Popescu CM, Ursache AL, Feketea G, Bocsan C, Jimbu L, Mesaros O, Edwards M, Wang H, Berceanu I, Neaga A, Zdrenghea M. Are Community Acquired Respiratory Viral Infections an Underestimated Burden in Hematology Patients? Microorganisms 2019;7:E521. [PMID: 31684063 DOI: 10.3390/microorganisms7110521] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
39 Renaud C, Campbell AP. Changing epidemiology of respiratory viral infections in hematopoietic cell transplant recipients and solid organ transplant recipients. Curr Opin Infect Dis 2011;24:333-43. [PMID: 21666460 DOI: 10.1097/QCO.0b013e3283480440] [Cited by in Crossref: 90] [Cited by in F6Publishing: 50] [Article Influence: 8.2] [Reference Citation Analysis]
40 Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses 2013;7 Suppl 3:60-6. [PMID: 24215383 DOI: 10.1111/irv.12170] [Cited by in Crossref: 32] [Cited by in F6Publishing: 25] [Article Influence: 4.0] [Reference Citation Analysis]
41 Marzoratti L, Iannella HA, Gómez VF, Figueroa SB. Recent advances in the diagnosis and treatment of influenza pneumonia. Curr Infect Dis Rep 2012;14:275-83. [PMID: 22477036 DOI: 10.1007/s11908-012-0257-5] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
42 Garcia-vidal C, Barba P, Arnan M, Moreno A, Ruiz-camps I, Gudiol C, Ayats J, Orti G, Carratala J. Invasive Aspergillosis Complicating Pandemic Influenza A (H1N1) Infection in Severely Immunocompromised Patients. Clinical Infectious Diseases 2011;53:e16-9. [DOI: 10.1093/cid/cir485] [Cited by in Crossref: 66] [Cited by in F6Publishing: 59] [Article Influence: 6.0] [Reference Citation Analysis]
43 Teh BW, Harrison SJ, Pellegrini M, Thursky KA, Worth LJ, Slavin MA. Changing treatment paradigms for patients with plasma cell myeloma: impact upon immune determinants of infection. Blood Rev 2014;28:75-86. [PMID: 24582081 DOI: 10.1016/j.blre.2014.01.004] [Cited by in Crossref: 37] [Cited by in F6Publishing: 34] [Article Influence: 4.6] [Reference Citation Analysis]
44 Kmeid J, Vanichanan J, Shah DP, El Chaer F, Azzi J, Ariza-Heredia EJ, Hosing C, Mulanovich V, Chemaly RF. Outcomes of Influenza Infections in Hematopoietic Cell Transplant Recipients: Application of an Immunodeficiency Scoring Index. Biol Blood Marrow Transplant 2016;22:542-8. [PMID: 26638804 DOI: 10.1016/j.bbmt.2015.11.015] [Cited by in Crossref: 49] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
45 Liu Y, Wang Y, Mai H, Chen Y, Liu B, Liu Y, Ji Y, Cong X, Gao Y. Clinical characteristics, risk factors and antiviral treatments of influenza in immunosuppressed inpatients in Beijing during the 2015-2020 influenza seasons. Virol J 2022;19:11. [PMID: 35033116 DOI: 10.1186/s12985-021-01739-1] [Reference Citation Analysis]
46 Hermann B, Lehners N, Brodhun M, Boden K, Hochhaus A, Kochanek M, Meckel K, Mayer K, Rachow T, Rieger C, Schalk E, Weber T, Schmeier-Jürchott A, Schlattmann P, Teschner D, von Lilienfeld-Toal M. Influenza virus infections in patients with malignancies -- characteristics and outcome of the season 2014/15. A survey conducted by the Infectious Diseases Working Party (AGIHO) of the German Society of Haematology and Medical Oncology (DGHO). Eur J Clin Microbiol Infect Dis 2017;36:565-73. [PMID: 27838792 DOI: 10.1007/s10096-016-2833-3] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 3.7] [Reference Citation Analysis]
47 Cordero E, de la Torre-Cisneros J, Moreno A, Pérez-Romero P, Riera M. The impact of influenza A(H1N1)pdm09 infection on immunosuppressed patients. Enferm Infecc Microbiol Clin 2012;30 Suppl 4:38-42. [PMID: 23116791 DOI: 10.1016/S0213-005X(12)70103-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
48 Weigt SS, Gregson AL, Deng JC, Lynch JP 3rd, Belperio JA. Respiratory viral infections in hematopoietic stem cell and solid organ transplant recipients. Semin Respir Crit Care Med 2011;32:471-93. [PMID: 21858751 DOI: 10.1055/s-0031-1283286] [Cited by in Crossref: 69] [Cited by in F6Publishing: 60] [Article Influence: 6.3] [Reference Citation Analysis]
49 Burke J, Soubani AO. Influenza and Pneumocystis jirovecii pneumonia in an allogeneic hematopoietic stem cell transplantation recipient: Coinfection or superinfection? Transpl Infect Dis 2018;20. [PMID: 29111605 DOI: 10.1111/tid.12802] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
50 Shahani L, Ariza-Heredia EJ, Chemaly RF. Antiviral therapy for respiratory viral infections in immunocompromised patients. Expert Rev Anti Infect Ther 2017;15:401-15. [PMID: 28067078 DOI: 10.1080/14787210.2017.1279970] [Cited by in Crossref: 17] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
51 Ljungman P, de la Camara R, Perez-Bercoff L, Abecasis M, Nieto Campuzano JB, Cannata-Ortiz MJ, Cordonnier C, Einsele H, Gonzalez-Vicent M, Espigado I, Halter J, Martino R, Mohty B, Sucak G, Ullmann AJ, Vázquez L, Ward KN, Engelhard D; Infectious Diseases Working Party, European Group for Blood and Marrow Transplantation., Infectious Complications Subcommittee, Spanish Group of Haematopoietic Stem-cell Transplantation. Outcome of pandemic H1N1 infections in hematopoietic stem cell transplant recipients. Haematologica 2011;96:1231-5. [PMID: 21546495 DOI: 10.3324/haematol.2011.041913] [Cited by in Crossref: 90] [Cited by in F6Publishing: 73] [Article Influence: 8.2] [Reference Citation Analysis]
52 Iioka F, Sada R, Maesako Y, Nakamura F, Ohno H. Outbreak of pandemic 2009 influenza A/H1N1 infection in the hematology ward: fatal clinical outcome of hematopoietic stem cell transplant recipients and emergence of the H275Y neuraminidase mutation. Int J Hematol 2012;96:364-9. [PMID: 22773299 DOI: 10.1007/s12185-012-1139-1] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
53 Vilar-Compte D, Shah DP, Vanichanan J, Cornejo-Juarez P, Garcia-Horton A, Volkow P, Chemaly RF. Influenza in patients with hematological malignancies: Experience at two comprehensive cancer centers. J Med Virol 2018;90:50-60. [PMID: 28851056 DOI: 10.1002/jmv.24930] [Cited by in Crossref: 17] [Cited by in F6Publishing: 12] [Article Influence: 3.4] [Reference Citation Analysis]
54 Piñana JL, Pérez A, Montoro J, Giménez E, Gómez MD, Lorenzo I, Madrid S, González EM, Vinuesa V, Hernández-Boluda JC, Salavert M, Sanz G, Solano C, Sanz J, Navarro D. Clinical Effectiveness of Influenza Vaccination After Allogeneic Hematopoietic Stem Cell Transplantation: A Cross-sectional, Prospective, Observational Study. Clin Infect Dis 2019;68:1894-903. [PMID: 30239624 DOI: 10.1093/cid/ciy792] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 8.5] [Reference Citation Analysis]
55 Wang CH, Chung FT, Lin SM, Huang SY, Chou CL, Lee KY, Lin TY, Kuo HP. Adjuvant treatment with a mammalian target of rapamycin inhibitor, sirolimus, and steroids improves outcomes in patients with severe H1N1 pneumonia and acute respiratory failure. Crit Care Med. 2014;42:313-321. [PMID: 24105455 DOI: 10.1097/ccm.0b013e3182a2727d] [Cited by in Crossref: 80] [Cited by in F6Publishing: 58] [Article Influence: 10.0] [Reference Citation Analysis]
56 Chemaly RF, Vigil KJ, Saad M, Vilar-Compte D, Cornejo-Juarez P, Perez-Jimenez C, Mubarak S, Salhab M, Jiang Y, Granwehr B, Adachi JA, Raad II. A multicenter study of pandemic influenza A (H1N1) infection in patients with solid tumors in 3 countries: early therapy improves outcomes. Cancer. 2012;118:4627-4633. [PMID: 22359314 DOI: 10.1002/cncr.27447] [Cited by in Crossref: 44] [Cited by in F6Publishing: 36] [Article Influence: 4.4] [Reference Citation Analysis]
57 Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H, Kang I;  Infectious Diseases Society of America. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis. 2014;58:e44-100. [PMID: 24311479 DOI: 10.1093/cid/cit684] [Cited by in Crossref: 419] [Cited by in F6Publishing: 350] [Article Influence: 46.6] [Reference Citation Analysis]
58 Wilson KE, Wood SM, Schaecher KE, Cromwell KB, Godich J, Knapp MH, Sklar MJ, Ewing D, Raviprakash K, Defang G, Whitman TJ. Nosocomial outbreak of influenza A H3N2 in an inpatient oncology unit related to health care workers presenting to work while ill. Am J Infect Control 2019;47:683-7. [PMID: 30616930 DOI: 10.1016/j.ajic.2018.10.024] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
59 Marinelli T, Wee LYA, Rowe E, Chhetri R, Friel O, Higgins G, Bardy P, Singhal D, Pradhan A, Crawford L, Hiwase DK. Respiratory Viruses Cause Late Morbidity in Recipients of Hematopoietic Stem Cell Transplantation. Biol Blood Marrow Transplant 2020;26:782-8. [PMID: 31866345 DOI: 10.1016/j.bbmt.2019.12.724] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
60 de Lima CR, Mirandolli TB, Carneiro LC, Tusset C, Romer CM, Andreolla HF, Baethgen LF, Pasqualotto AC. Prolonged respiratory viral shedding in transplant patients. Transpl Infect Dis 2014;16:165-9. [PMID: 24289829 DOI: 10.1111/tid.12167] [Cited by in Crossref: 31] [Cited by in F6Publishing: 30] [Article Influence: 3.4] [Reference Citation Analysis]
61 Hong KW, Choi SM, Lee DG, Cho SY, Lee HJ, Choi JK, Kim SH, Park SH, Choi JH, Yoo JH, Lee JW. Lower Respiratory Tract Diseases Caused by Common Respiratory Viruses among Stem Cell Transplantation Recipients: A Single Center Experience in Korea. Yonsei Med J 2017;58:362-9. [PMID: 28120567 DOI: 10.3349/ymj.2017.58.2.362] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
62 Seo S, Waghmare A, Scott EM, Xie H, Kuypers JM, Hackman RC, Campbell AP, Choi SM, Leisenring WM, Jerome KR, Englund JA, Boeckh M. Human rhinovirus detection in the lower respiratory tract of hematopoietic cell transplant recipients: association with mortality. Haematologica 2017;102:1120-30. [PMID: 28183847 DOI: 10.3324/haematol.2016.153767] [Cited by in Crossref: 44] [Cited by in F6Publishing: 38] [Article Influence: 8.8] [Reference Citation Analysis]
63 Pollara CP, Piccinelli G, Rossi G, Cattaneo C, Perandin F, Corbellini S, Tomasi DD, Bonfanti C. Nosocomial outbreak of the pandemic Influenza A (H1N1) 2009 in critical hematologic patients during seasonal influenza 2010-2011: detection of oseltamivir resistant variant viruses. BMC Infect Dis 2013;13:127. [PMID: 23496867 DOI: 10.1186/1471-2334-13-127] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
64 Rodrigo C, Leonardi-Bee J, Nguyen-Van-Tam J, Lim WS. Corticosteroids as adjunctive therapy in the treatment of influenza. Cochrane Database Syst Rev. 2016;3:CD010406. [PMID: 26950335 DOI: 10.1002/14651858.cd010406.pub2] [Cited by in Crossref: 32] [Cited by in F6Publishing: 41] [Article Influence: 5.3] [Reference Citation Analysis]
65 Ogimi C, Waghmare AA, Kuypers JM, Xie H, Yeung CC, Leisenring WM, Seo S, Choi SM, Jerome KR, Englund JA, Boeckh M. Clinical Significance of Human Coronavirus in Bronchoalveolar Lavage Samples From Hematopoietic Cell Transplant Recipients and Patients With Hematologic Malignancies. Clin Infect Dis 2017;64:1532-9. [PMID: 28329354 DOI: 10.1093/cid/cix160] [Cited by in Crossref: 50] [Cited by in F6Publishing: 44] [Article Influence: 12.5] [Reference Citation Analysis]
66 Yue MC, Collins JT, Subramoniapillai E, Kennedy GA. Successful use of oseltamivir prophylaxis in managing a nosocomial outbreak of influenza A in a hematology and allogeneic stem cell transplant unit. Asia Pac J Clin Oncol 2017;13:37-43. [PMID: 27730741 DOI: 10.1111/ajco.12565] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
67 Abed Y, Bouhy X, L'Huillier AG, Rhéaume C, Pizzorno A, Retamal M, Fage C, Dubé K, Joly MH, Beaulieu E, Mallett C, Kaiser L, Boivin G. The E119D neuraminidase mutation identified in a multidrug-resistant influenza A(H1N1)pdm09 isolate severely alters viral fitness in vitro and in animal models. Antiviral Res 2016;132:6-12. [PMID: 27185624 DOI: 10.1016/j.antiviral.2016.05.006] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
68 Hijano DR, Maron G, Hayden RT. Respiratory Viral Infections in Patients With Cancer or Undergoing Hematopoietic Cell Transplant. Front Microbiol 2018;9:3097. [PMID: 30619176 DOI: 10.3389/fmicb.2018.03097] [Cited by in Crossref: 31] [Cited by in F6Publishing: 25] [Article Influence: 7.8] [Reference Citation Analysis]
69 Tsigrelis C, Ljungman P. Vaccinations in patients with hematological malignancies. Blood Rev 2016;30:139-47. [PMID: 26602587 DOI: 10.1016/j.blre.2015.10.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 14] [Article Influence: 3.4] [Reference Citation Analysis]
70 Chen L, Han X, Li Y, Zhang C, Xing X. The severity and risk factors for mortality in immunocompromised adult patients hospitalized with influenza-related pneumonia. Ann Clin Microbiol Antimicrob 2021;20:55. [PMID: 34429126 DOI: 10.1186/s12941-021-00462-7] [Reference Citation Analysis]
71 Choi SM, Xie H, Campbell AP, Kuypers J, Leisenring W, Boudreault AA, Englund JA, Corey L, Boeckh M. Influenza viral RNA detection in blood as a marker to predict disease severity in hematopoietic cell transplant recipients. J Infect Dis 2012;206:1872-7. [PMID: 23033148 DOI: 10.1093/infdis/jis610] [Cited by in Crossref: 29] [Cited by in F6Publishing: 21] [Article Influence: 2.9] [Reference Citation Analysis]
72 Atalla E, Kalligeros M, Mylona EK, Tsikala-Vafea M, Shehadeh F, Georgakas J, Mylonakis E. Impact of Influenza Infection Among Adult and Pediatric Populations With Hematologic Malignancy and Hematopoietic Stem Cell Transplant: A Systematic Review and Meta-Analysis. Clin Ther 2021;43:e66-85. [PMID: 33812700 DOI: 10.1016/j.clinthera.2021.03.002] [Reference Citation Analysis]
73 Fontana L, Strasfeld L. Respiratory Virus Infections of the Stem Cell Transplant Recipient and the Hematologic Malignancy Patient. Infect Dis Clin North Am 2019;33:523-44. [PMID: 30940462 DOI: 10.1016/j.idc.2019.02.004] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 6.3] [Reference Citation Analysis]
74 Schiffer JT, Johnston C, Wald A, Corey L. An Early Test-and-Treat Strategy for Severe Acute Respiratory Syndrome Coronavirus 2. Open Forum Infect Dis 2020;7:ofaa232. [PMID: 32661497 DOI: 10.1093/ofid/ofaa232] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
75 Ogimi C, Xie H, Waghmare A, Ueda Oshima M, Mallhi KK, Jerome KR, Leisenring WM, Englund JA, Boeckh M. Risk factors for seasonal human coronavirus lower respiratory tract infection after hematopoietic cell transplantation. Blood Adv 2021;5:1903-14. [PMID: 33792629 DOI: 10.1182/bloodadvances.2020003865] [Reference Citation Analysis]
76 Shah RD, Wunderink RG. Viral Pneumonia and Acute Respiratory Distress Syndrome. Clin Chest Med 2017;38:113-25. [PMID: 28159154 DOI: 10.1016/j.ccm.2016.11.013] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.8] [Reference Citation Analysis]
77 Waghmare A, Englund JA, Boeckh M. How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. Blood 2016;127:2682-92. [PMID: 26968533 DOI: 10.1182/blood-2016-01-634873] [Cited by in Crossref: 46] [Cited by in F6Publishing: 39] [Article Influence: 7.7] [Reference Citation Analysis]
78 Harish MM, Ruhatiya RS. Influenza H1N1 infection in immunocompromised host: A concise review. Lung India 2019;36:330-6. [PMID: 31290419 DOI: 10.4103/lungindia.lungindia_464_18] [Reference Citation Analysis]
79 Abed Y, Boivin G. A Review of Clinical Influenza A and B Infections With Reduced Susceptibility to Both Oseltamivir and Zanamivir. Open Forum Infect Dis 2017;4:ofx105. [PMID: 28852674 DOI: 10.1093/ofid/ofx105] [Cited by in Crossref: 24] [Cited by in F6Publishing: 23] [Article Influence: 4.8] [Reference Citation Analysis]
80 Waghmare A, Xie H, Kuypers J, Sorror ML, Jerome KR, Englund JA, Boeckh M, Leisenring WM. Human Rhinovirus Infections in Hematopoietic Cell Transplant Recipients: Risk Score for Progression to Lower Respiratory Tract Infection. Biol Blood Marrow Transplant 2019;25:1011-21. [PMID: 30537551 DOI: 10.1016/j.bbmt.2018.12.005] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 2.8] [Reference Citation Analysis]
81 Conrad A, Alcazer V, Valour F, Ader F. Vaccination post-allogeneic hematopoietic stem cell transplantation: what is feasible? Expert Review of Vaccines 2018;17:299-309. [DOI: 10.1080/14760584.2018.1449649] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
82 Nguyen JT, Smee DF, Barnard DL, Julander JG, Gross M, de Jong MD, Went GT. Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A viruses. PLoS One 2012;7:e31006. [PMID: 22292088 DOI: 10.1371/journal.pone.0031006] [Cited by in Crossref: 60] [Cited by in F6Publishing: 61] [Article Influence: 6.0] [Reference Citation Analysis]
83 Reid G, Huprikar S, Patel G, Razonable RR, Mossad S, Levi M, Gregg K, Shoham S, Humar A, Adams W, Kumar D. A multicenter evaluation of pandemic influenza A/H1N1 in hematopoietic stem cell transplant recipients. Transpl Infect Dis 2013;15:487-92. [PMID: 23890293 DOI: 10.1111/tid.12116] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.6] [Reference Citation Analysis]
84 Gabutti G, De Motoli F, Sandri F, Toffoletto MV, Stefanati A. Viral Respiratory Infections in Hematological Patients. Infect Dis Ther 2020;9:495-510. [PMID: 32638228 DOI: 10.1007/s40121-020-00313-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
85 Dyer G, Gilroy N, Brice L, Kabir M, Gottlieb D, Huang G, Hogg M, Brown L, Greenwood M, Larsen SR, Moore J, Hertzberg M, Tan J, Ward C, Kerridge I. A survey of infectious diseases and vaccination uptake in long-term hematopoietic stem cell transplant survivors in Australia. Transpl Infect Dis 2019;21:e13043. [PMID: 30585673 DOI: 10.1111/tid.13043] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
86 Bacigalupo A, Metafuni E, Amato V, Marquez Algaba E, Pagano L. Reducing infectious complications after allogeneic stem cell transplant. Expert Rev Hematol 2020;13:1235-51. [PMID: 32996342 DOI: 10.1080/17474086.2020.1831382] [Reference Citation Analysis]
87 Green ML. Viral Pneumonia in Patients with Hematopoietic Cell Transplantation and Hematologic Malignancies. Clin Chest Med 2017;38:295-305. [PMID: 28477640 DOI: 10.1016/j.ccm.2016.12.009] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]